Hofheim am Taunus, Germany

Theo Wollmann

This inventor holds 1 USPTO granted patent. Top assignee: Hoechst Aktiengesellschaft. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Theo Wollmann. Retrieved from https://idiyas.com/inventor/theo-wollmann-xnr03f8v

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Theo Wollmann

Introduction

Theo Wollmann is a notable inventor based in Hofheim am Taunus, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibiotics. His work has led to advancements that are crucial for medical applications.

Latest Patents

Wollmann holds a patent for "Tetracyclic antibiotics and processes for their preparation." This patent focuses on β-Lactam antibiotics of a specific formula, which includes various pharmaceutically tolerable salts. His innovative approach in this area has the potential to enhance the effectiveness of antibiotic treatments.

Career Highlights

Throughout his career, Theo Wollmann has been associated with Hoechst Aktiengesellschaft, a prominent company in the pharmaceutical industry. His work there has allowed him to explore and develop new antibiotic formulations that address critical health challenges.

Collaborations

Wollmann has collaborated with esteemed colleagues, including Uwe Gerlach and Rolf Horlein. These partnerships have fostered a creative environment that encourages the exchange of ideas and expertise in the field of antibiotic research.

Conclusion

Theo Wollmann's contributions to antibiotic development exemplify the impact of innovative thinking in pharmaceuticals. His patent and collaborations highlight the importance of teamwork in advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…